Kazia Therapeutics Limited (KZIA)

NASDAQ: KZIA · Real-Time Price · USD

8.11

-0.41 (-4.81%)

At close: Mar 11, 2026, 4:00 PM EDT

8.10

-0.01 (-0.12%)

After-hours: Mar 11, 2026, 5:03 PM EDT

Kazia Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Revenue	1.83	2.48	0
Revenue Growth (YoY)	-26.28%	248000.00%	-
Gross Profit	1.83	2.48	0
Selling, General & Admin	8.72	13.56	8.58
Research & Development	7.33	17.38	15.56
Other Operating Expenses	13.38	-	-
Total Operating Expenses	29.43	30.94	24.15
Operating Income	-27.6	-28.46	-24.15
Interest Income	0.07	0.01	0.02
Other Non-Operating Income (Expense)	5.08	1.38	3.39
Total Non-Operating Income (Expense)	5.15	1.39	3.41
Pretax Income	-22.45	-27.05	-20.74
Provision for Income Taxes	-1.75	-0.27	-0.27
Net Income	-20.7	-26.78	-20.47
Net Income to Common	-20.7	-26.78	-20.47
Shares Outstanding (Basic)	1	1	0
Shares Outstanding (Diluted)	1	1	0
Shares Change (YoY)	107.81%	43.08%	-
EPS (Basic)	-18.90	-50.80	-56.15
EPS (Diluted)	-18.90	-50.80	-56.15
Free Cash Flow	-13.28	-9.58	-15.16
Free Cash Flow Per Share	-12.12	-18.17	-41.12
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-1508.80%	-1147.20%	-2414600.00%
Profit Margin	-1131.88%	-1079.32%	-2046500.00%
FCF Margin	-725.97%	-386.17%	-1515600.00%
EBITDA	-26.66	-26.59	-22.28
EBITDA Margin	-1457.74%	-1071.87%	-2227700.00%
EBIT	-27.6	-28.46	-24.15
EBIT Margin	-1508.80%	-1147.20%	-2414600.00%
Effective Tax Rate	7.78%	1.00%	1.31%

Updated Nov 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q